G
GENB
Generate Biomedicines
17.72
+1.60+9.93%After Hours: 17.96 +0.24 +1.35%19:57 08/24 EDT
OPEN/PREV CLOSE16.67/16.12
TODAY RANGE16.03-17.99
VOL2.50M
MARKET CAP2.27B
52 WEEK RANGE11.00-18.18
AVG VOL (3M)841.37K
% TURNOVER1.95%
TURNOVER--
P/E (TTM)-11.1369
% RANGE12.13%
EPS(TTM)-1.5911
P/E(FORWARD)-7.5970
P/B4.984
BVPS3.555
DIVIDEND--
P/S70.82
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.92B
SHARES OUTSTANDING128.35M
NEXT EARNINGS--
FREE FLOAT108.60M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/17 12:57
Morgan Stanley Sticks to Its Buy Rating for Generate Biomedicines, Inc. (GENB)
Seeking Alpha·08/14 21:04
Nvidia discloses big stake in SpaceX in Q2 moves
Seeking Alpha·08/10 23:22
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
TipRanks·08/07 12:09
Piper Sandler Remains a Buy on Generate Biomedicines, Inc. (GENB)
Seeking Alpha·08/06 17:17
Generate Biomedicines, Inc. reports Q2 results
TipRanks·08/06 12:06
Generate Biomedicines reports Q2 EPS (52c), consensus (49c)
Dow Jones·08/06 11:15
*Generate Biomedicines 2Q Loss/Shr 52c >GENB
Dow Jones·08/06 11:15
*Generate Biomedicines 2Q Rev $6.31M >GENB
Dow Jones·08/06 11:15
*Generate Biomedicines 2Q Loss $67.3M >GENB
Dow Jones·08/06 11:00
Press Release: Generate Biomedicines Inc. Reports -2-
Seeking Alpha·07/23 21:41
Generate Biomedicines: Post Mega-Money IPO, Caution Is Warranted
Seeking Alpha·07/13 11:10
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
TipRanks·07/10 16:05
Generate Biomedicines falls -9.5%
Same Industry
Name/Symbol
Change%
Price